Cargando…

Syndecan Binding Protein (SDCBP) Is Overexpressed in Estrogen Receptor Negative Breast Cancers, and Is a Potential Promoter for Tumor Proliferation

BACKGROUND: Syndecan binding protein (SDCBP), an adapter protein containing PDZ domains, contributes to the tumorigenicity and metastasis of many malignant tumors, such as malignant melanoma. Our study aimed in revealing the expression profile of SDCBP in breast cancer (BCa) and its role in tumor ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Xiao-Long, Li, Ya-Qing, Yu, Bin, Gu, Feng, Liu, Fang-Fang, Li, Wei-Dong, Zhang, Xin-Min, Fu, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606191/ https://www.ncbi.nlm.nih.gov/pubmed/23533663 http://dx.doi.org/10.1371/journal.pone.0060046

Ejemplares similares

Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP)
por: Qian, Xiao-Long, et al.
Publicado: (2017)

Silencing of syndecan-binding protein enhances the inhibitory effect of tamoxifen and increases cellular sensitivity to estrogen
por: Zhang, Jun, et al.
Publicado: (2018)

PRKAR1A and SDCBP Serve as Potential Predictors of Heart Failure Following Acute Myocardial Infarction
por: Chen, Qixin, et al.
Publicado: (2022)

Syndecan-1 Enhances Proliferation, Migration and Metastasis of HT-1080 Cells in Cooperation with Syndecan-2
por: Péterfia, Bálint, et al.
Publicado: (2012)

Single‐cell RNA sequencing identify SDCBP in ACE2‐positive bronchial epithelial cells negatively correlates with COVID‐19 severity
por: Ma, Ding, et al.
Publicado: (2021)

SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation
por: Mir, Cristina, et al.
Publicado: (2021)

Syndecan-1 Overexpressing Mesothelioma Cells Inhibit Proliferation, Wound Healing, and Tube Formation of Endothelial Cells
por: Javadi, Joman, et al.
Publicado: (2021)

Correction to Single‐cell RNA sequencing identify SDCBP in ACE2‐positive bronchial epithelial cells negatively correlates with COVID‐19 severity
Publicado: (2023)

High glucose-induced intestinal epithelial barrier damage is aggravated by syndecan-1 destruction and heparanase overexpression
por: Qing, Qing, et al.
Publicado: (2015)

SDCBP‐AS1 destabilizes β‐catenin by regulating ubiquitination and SUMOylation of hnRNP K to suppress gastric tumorigenicity and metastasis
por: Han, Jing, et al.
Publicado: (2022)

Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells
por: Talukdar, Sarmistha, et al.
Publicado: (2016)

Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis
por: Das, Swadesh K., et al.
Publicado: (2016)

MDA-9/Syntenin (SDCBP) Is a Critical Regulator of Chemoresistance, Survival and Stemness in Prostate Cancer Stem Cells
por: Talukdar, Sarmistha, et al.
Publicado: (2019)

HAX-1 overexpression in gastric cancer promotes cell proliferation
por: Gu, Shudong, et al.
Publicado: (2020)

Overexpression of hyaluronan-binding protein 1 promotes the proliferation, migration, and invasion of malignant glioma
por: Yang, Zijun, et al.
Publicado: (2020)

Overexpression of Human Syndecan-1 Protects against the Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice
por: Reszegi, Andrea, et al.
Publicado: (2021)

Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression
por: Wang, Chuying, et al.
Publicado: (2018)

DISC1 overexpression promotes non-small cell lung cancer cell proliferation
por: Wang, Shuo, et al.
Publicado: (2017)

Long non-coding RNA SDCBP2-AS1 delays the progression of ovarian cancer via microRNA-100-5p-targeted EPDR1
por: Liu, Xiu, et al.
Publicado: (2021)

Serum Levels of Syndecan-1 in Patients With Kawasaki Disease
por: Luo, Li, et al.
Publicado: (2019)

Hypoxia Promotes Syndecan-3 Expression in the Tumor Microenvironment
por: Prieto-Fernández, Endika, et al.
Publicado: (2020)

Syndecan-4 negatively regulates antiviral signalling by mediating RIG-I deubiquitination via CYLD
por: Lin, Wei, et al.
Publicado: (2016)

Novel Genes and Pathways Modulated by Syndecan-1: Implications for the Proliferation and Cell-Cycle Regulation of Malignant Mesothelioma Cells
por: Szatmári, Tünde, et al.
Publicado: (2012)

Syndecan-3 and syndecan-4 are enriched in Schwann cell perinodal processes
por: Goutebroze, Laurence, et al.
Publicado: (2003)

Overexpression of lncRNA TATDN1 Promotes Cancer Cell Proliferation in Triple Negative Breast Cancer by Regulating miR-26b Methylation
por: Long, Quanyi, et al.
Publicado: (2020)

Overexpression of TMPRSS4 promotes tumor proliferation and aggressiveness in breast cancer
por: Li, Xiao-Mei, et al.
Publicado: (2017)

Heparanase overexpression down-regulates syndecan-1 expression in a gallbladder carcinoma cell line
por: Jin, Hao, et al.
Publicado: (2017)

Syndecan-1 Is Overexpressed in Human Thoracic Aneurysm but Is Dispensable for the Disease Progression in a Mouse Model
por: Zalghout, Sara, et al.
Publicado: (2022)

Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis
por: Cerbelli, Bruna, et al.
Publicado: (2022)

UBE2C Overexpression Aggravates Patient Outcome by Promoting Estrogen-Dependent/Independent Cell Proliferation in Early Hormone Receptor-Positive and HER2-Negative Breast Cancer
por: Kim, Yu-Jin, et al.
Publicado: (2020)

Sarm1, a negative regulator of innate immunity, interacts with syndecan-2 and regulates neuronal morphology
por: Chen, Chiung-Ya, et al.
Publicado: (2011)

AGR3 promotes estrogen receptor-positive breast cancer cell proliferation in an estrogen-dependent manner
por: Jian, Lei, et al.
Publicado: (2020)

Selective estrogen receptor modulator with estrogen does not affect the proliferation and apoptosis of uterine leiomyoma cells
por: Lv, Shu-Lan, et al.
Publicado: (2020)

microRNA-206 overexpression inhibits cellular proliferation and invasion of estrogen receptor α-positive ovarian cancer cells
por: Li, Shaoru, et al.
Publicado: (2021)

PFKFB4 Overexpression Facilitates Proliferation by Promoting the G1/S Transition and Is Associated with a Poor Prognosis in Triple-Negative Breast Cancer
por: Cai, Yu-Chen, et al.
Publicado: (2021)

LRP8 is overexpressed in estrogen‐negative breast cancers and a potential target for these tumors
por: Maire, Virginie, et al.
Publicado: (2018)

Histone Demethylase Retinoblastoma Binding Protein 2 is Overexpressed in Hepatocellular Carcinoma and Negatively Regulated by hsa-miR-212
por: Liang, Xiuming, et al.
Publicado: (2013)

Syndecan-4 modulates the proliferation of neural cells and the formation of CaP axons during zebrafish embryonic neurogenesis
por: Luo, Ning, et al.
Publicado: (2016)

Overexpression of PFKFB3 promotes cell glycolysis and proliferation in renal cell carcinoma
por: Li, Jun, et al.
Publicado: (2022)

Overexpression of Long Noncoding RNA LBX2-AS1 Promotes the Proliferation of Colorectal Cancer
por: Li, Qing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jd2ic2l4ah7p7d2st62hhen5jf